New test for timing delivery in severe preeclampsia
Part of Women’s health & pregnancy clinical trials.
This study is testing a new way to decide when to deliver the baby by measuring certain proteins in your blood. The goal is to better manage severe preeclampsia and improve outcomes for you and your baby.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must be pregnant with one baby only.
- You must have severe preeclampsia diagnosed between 30 and 33 weeks of pregnancy.
- Your baby must not have major birth defects or genetic conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at genes that may be linked to severe preeclampsia, a serious pregnancy condition. By comparing women with severe preeclampsia to those with normal pregnancies, researchers hope to find clues that could lead to better prevention or treatment.
This study tests whether measuring certain proteins in the blood (angiogenic factors) can help doctors better manage preeclampsia in women who are 36 to 38 weeks pregnant. The goal is to see if this approach can safely delay delivery and improve outcomes for both mother and baby.
This trial tests whether measuring two pregnancy blood markers (sFlt1 and PlGF) and planning delivery timing can help prevent preeclampsia as you reach term. It may help reduce risk for mother and baby by guiding when to deliver based on test results.
This trial tests a new medicine, CBP-4888, for pregnant women hospitalized with preeclampsia starting after 20 weeks. The goal is to see if it's safe and how it works for you and your baby, who will be followed for up to 24 months after birth.
This study is for pregnant women to check their risk of pre-eclampsia (a serious condition causing high blood pressure) using simple tests like blood work or ultrasound. It aims to help you and your doctor manage your pregnancy better.
This study looks at two ways to manage early-onset fetal growth restriction (when a baby is smaller than expected). It compares using blood tests for angiogenic factors versus feto-placental Doppler ultrasound to guide care. The goal is to find the best way to monitor and protect your baby's health.
Hear when a new Severe Preeclampsia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.